The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/16537
StudyName: Eligibility Carcinoma, Squamous Cell NCT02254044
Date of export from the portal: 02.07.2020
Date of Upload / last change: 23.07.2016
License: Creative Commons BY 4.0

----

Description: 
Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus; ODM derived from: https://clinicaltrials.gov/show/NCT02254044
